Mylotarg Makes a Comeback for Leukemia
Mylotarg was heralded as the first targeted therapy for leukemia in the U.S. in 2000, but it was withdrawn when further testing showed increased mortality rates. After extensive testing, it is back on the market with a new dosing and more refined criteria for which patients are likely to respond to...
| Other Authors: | Infobase,, Ivanhoe Broadcast News (Firm) |
|---|---|
| Format: | Video |
| Language: | English |
| Published: |
[Place of publication not identified] :
Ivanhoe Broadcast News,
[2018]
Distributed by Infobase, |
| Physical Description: |
1 online resource (1 video file (1 min., 34 sec)) : sound, color. |
| Series: |
Medical Breakthroughs.
|
| Subjects: |